Edwards Lifesciences v Meril Italy (CFI, 30 April 2024)
| Date | 30 April 2024 |
|---|---|
| Court | CFI |
| Division | Paris (FR) Central Division - Seat |
| Type of action | Generic application |
| Case number(s) | UPC_CFI_255/2023 |
| Registry reference | App_19959/2024and23242/2024 · ORD_24620/2024 · UPC_CFI_255/2023 |
| Parties | Edwards Lifesciences Corporation v. Meril Italy srl |
Official decision (PDF) · UPC registry entry
Case timeline
- 13 November 2023 : Edwards Lifesciences v Meril Italy (CFI, 13 November 2023) ORD_578356/2023 · UPC_CFI_255/2023
- 27 February 2024 : Meril Italy v Edwards Lifesciences (CFI, UPC_CFI_255/2023, ORD_7184/2024, 27 February 2024) ORD_7184/2024 · App_7184/2024 · UPC_CFI_255/2023
- 27 February 2024 : Meril Italy v Edwards Lifesciences (CFI, UPC_CFI_255/2023, ORD_7184/2024, 27 February 2024, doc. 2) App_7184/2024 · ORD_7184/2024 · UPC_CFI_255/2023
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By an order of 30 April 2024 (UPC_CFI_255/2023, ACT_551308/2023, App_19959/2024 and App_23242/2024), the judge-rapporteur of panel 2 of the Paris Central Division (P. Catallozzi), in the revocation action brought by Meril Italy s.r.l. against EP 3 646 825, admitted the subsequent request to amend the patent lodged by Edwards Lifesciences Corporation after the written procedure had closed, and gave Meril one month to respond. The order accepts a late amendment where it narrows the dispute.
Question
May a subsequent request to amend the patent (Rule 30.2 RoP), lodged after the written procedure has closed, be admitted, and on what conditions?
Decision
A subsequent request requires the court’s permission, which is discretionary even after the time for the Defence has expired (paragraphs 7 and 8), since no time limit is set, it may come after the written procedure has closed provided the other party’s right of defence is not prejudiced (paragraph 9). The judge weighs efficiency and the narrowing of the dispute against delay and the other side’s rights, and the requesting party must justify the change (paragraphs 10 to 13). Alignment with the defence to the counterclaim is no justification (paragraph 17), reducing 84 auxiliary requests to one unconditional amendment and six auxiliary requests, however, improves efficiency and is fair (paragraphs 18 to 20). Lack of agreement between the parties is no bar (paragraphs 21 to 23). One month is given for an additional defence, without reopening the written procedure (paragraphs 24 and 25), Meril’s request for a rejoinder was refused, Edwards’ unauthorised reply being disregarded (paragraph 26).
Key points for practice
- Practical point: a subsequent request to amend stands the best chance where it sharply reduces the number of auxiliary requests, the other side then receives time to respond, without the written procedure being reopened.
Provisions applied
- Rules of Procedure
- Rules 30, 50 and 263.1, and recitals 2 and 4 of the Preamble
- European Patent Convention
- Art. 84, 123(2) and (3)
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: Written procedure (UPC), Court fees and costs (UPC).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- claimantEdwards Lifesciences Corporation41 decisions in the corpusFollow this party
- defendantMeril Italy srl19 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 13 November 2023 Edwards Lifesciences v Meril Italy (CFI, 13 November 2023) Preliminary objection · UPC_CFI_255/2023
La division centrale reste compétente pour l'action en nullité de Meril Italy, filiale distincte des défenderesses à l'action en contrefaçon munichoise. La garantie pour les frais est refusée.
- 27 February 2024 Meril Italy v Edwards Lifesciences (CFI, UPC_CFI_255/2023, ORD_7184/2024, 27 February 2024) Generic application · UPC_CFI_255/2023
- 27 February 2024 Meril Italy v Edwards Lifesciences (CFI, UPC_CFI_255/2023, ORD_7184/2024, 27 February 2024, doc. 2) Generic application · UPC_CFI_255/2023
- 30 April 2024 Edwards Lifesciences v Meril Italy (CFI, 30 April 2024) Generic application · UPC_CFI_255/2023
What the record states
- Nature of the act
- Generic application
- Outcome (Dhenne Avocats summary)
- La demande ultérieure de modification du brevet est admise et Meril dispose d'un mois pour une défense complémentaire. La duplique est refusée.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 646 825mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Meril Italy v Edwards Lifesciences (CFI, UPC_CFI_255/2023, ORD_7184/2024, 27 February 2024) cited in this record
- Meril Italy v Edwards Lifesciences (CFI, UPC_CFI_255/2023, ORD_7184/2024, 27 February 2024, doc. 2) cited in this record
- Edwards Lifesciences v Meril Italy (CFI, 13 November 2023) cited in this record
- Meril Italy v Edwards Lifesciences (CoA, 6 September 2024) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 646 825A system comprising a prosthetic valve and a delivery catheter recorded proprietor: Edwards Lifesciences Corp | Mentioned in the analysis (role not qualified) Also mentioned in 32 other decision(s): Edwards Lifesciences v Meril Life Sciences (CFI, 15 November 2024) · Meril Italy v Edwards Lifesciences (CFI, 19 July 2024) · Meril v Edwards Lifesciences (CFI, 19 July 2024) · Meril Italy v Edwards Lifesciences (CoA, 25 November 2025) · Edwards Lifesciences v Sintec (CFI, 5 September 2025) · Meril Italy v SWAT Medical (CoA, 5 May 2025) · Meril v SWAT Medical (CoA, 5 May 2025) · Meril Life Sciences v SWAT Medical (CoA, 5 May 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.